{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:55:17Z","timestamp":1787680517228,"version":"build-2784847793"},"reference-count":42,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:sec>\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>H3 G34\u2013mutant diffuse hemispheric gliomas (G34m-DHGs) are rare and constitute a new infiltrating brain tumor entity whose characteristics require elucidation, and their difference from isocitrate dehydrogenase\u2013wild-type glioblastomas (IDH-WT-GBMs) needs to be clarified. In this study, the authors report the demographic, clinical, and neuroradiological features of G34m-DHG and investigate the capability of quantitative MRI features in differentiating them.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>Twenty-three patients with G34m-DHG and 30 patients with IDH-WT-GBM were included in this retrospective study. The authors reviewed the clinical, radiological, and molecular data of G34m-DHGs and compared their neuroimaging features with those of IDH-WT-GBMs in adolescents and young adults. Visually Accessible Rembrandt Images (VASARI) features were extracted, and the Kruskal-Wallis test was performed. A logistic regression model was constructed to evaluate the diagnostic performance for differentiating between G34m-DHG and IDH-WT-GBM. Subsequently, FeAture Explorer (FAE) was used to generate the machine learning pipeline and select important radiomics features that had been extracted with PyRadiomics. Estimates of the performance were supplied by metrics such as sensitivity, specificity, accuracy, and area under the curve (AUC).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>The mean age of the 23 patients with G34m-DHG was 23.7 years (range 11\u201345 years), younger than the mean age of patients with IDH-WT-GBM (30.96 years, range 5\u201343 years). All tumors were hemispheric. Most cases were immunonegative for ATRX (95%) and Olig2 (100%), were immunopositive for p53 (95%), and exhibited MGMT promoter methylation (81%). The radiological presentations of G34m-DHG were different from those of IDH-WT-GBM. The majority of the G34m-DHGs were in the frontal, parietal, and temporal lobes and demonstrated no or only faint contrast enhancement (74%), while IDH-WT-GBMs were mostly seen in the frontal lobe and showed marked contrast enhancement in 83% of cases. The FAE-generated model, based on radiomics features (AUC 0.925) of conventional MR images, had better discriminatory performance between G34m-DHG and IDH-WT-GBM than VASARI feature analysis (AUC 0.843).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSIONS<\/jats:title>\n<jats:p>G34m-DHGs most frequently occur in the frontal, parietal, and temporal lobes in adolescent and young adults and are associated with radiological characteristics distinct from those of IDH-WT-GBMs. Successful identification can be achieved by using either VASARI features or radiomics signatures, which may contribute to prognostic evaluation and assist in clinical settings.<\/jats:p>\n<\/jats:sec>","DOI":"10.3171\/2023.10.peds23235","type":"journal-article","created":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T02:03:19Z","timestamp":1703901799000},"page":"236-244","source":"Crossref","is-referenced-by-count":11,"title":["MRI characteristics of H3 G34\u2013mutant diffuse hemispheric gliomas and possible differentiation from IDH\u2013wild-type glioblastomas in adolescents and young adults"],"prefix":"10.3171","volume":"33","author":[{"given":"Hanbing","family":"Shao","sequence":"first","affiliation":[{"name":"Department of Radiology, Huaxi MR Research Center (HMRRC), West China Hospital of Sichuan University, Chengdu;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Pathology, West China Hospital of Sichuan University, Chengdu;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Radiology, Huaxi MR Research Center (HMRRC), West China Hospital of Sichuan University, Chengdu;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, West China Hospital of Sichuan University, Chengdu;"},{"name":"Huaxi Glioma Center, West China Hospital of Sichuan University, Chengdu;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiology, Huaxi MR Research Center (HMRRC), West China Hospital of Sichuan University, Chengdu;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xibiao","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Huaxi MR Research Center (HMRRC), West China Hospital of Sichuan University, Chengdu;"},{"name":"Department of Radiology, West China Hospital of Sichuan University, Chengdu;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Huaxi MR Research Center (HMRRC), West China Hospital of Sichuan University, Chengdu;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangfeng","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Huaxi MR Research Center (HMRRC), West China Hospital of Sichuan University, Chengdu;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Huaxi MR Research Center (HMRRC), West China Hospital of Sichuan University, Chengdu;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyong","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Radiology, Huaxi MR Research Center (HMRRC), West China Hospital of Sichuan University, Chengdu;"},{"name":"Department of Radiology, West China Xiamen Hospital of Sichuan University, Xiamen, Fujian; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaou","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Radiology, West China Hospital of Sichuan University, Chengdu;"},{"name":"Huaxi Glioma Center, West China Hospital of Sichuan University, Chengdu;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"8","key":"b1","series-title":"Neuro Oncol","first-page":"1231","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis DN","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P,  The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231\u20131251."},{"issue":"4","key":"b2","series-title":"Brain Pathol","first-page":"844","article-title":"cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading","volume":"30","author":"Louis DN","year":"2020","unstructured":"Louis DN, Wesseling P, Aldape K,  cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. Brain Pathol. 2020;30(4):844\u2013856."},{"issue":"7384","key":"b3","series-title":"Nature","first-page":"226","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber J","year":"2012","unstructured":"Schwartzentruber J, Korshunov A, Liu XY,  Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature. 2012;482(7384):226\u2013231."},{"issue":"5","key":"b4","series-title":"J Neuropathol Exp Neurol","first-page":"408","article-title":"Distinct histomorphology in molecular subgroups of glioblastomas in young patients","volume":"75","author":"Neumann JE","year":"2016","unstructured":"Neumann JE, Dorostkar MM, Korshunov A,  Distinct histomorphology in molecular subgroups of glioblastomas in young patients. J Neuropathol Exp Neurol. 2016;75(5):408\u2013414."},{"issue":"8","key":"b5","series-title":"Neuro Oncol","first-page":"1190","article-title":"High-grade gliomas in adolescents and young adults highlight histomolecular differences from their adult and pediatric counterparts","volume":"22","author":"Roux A","year":"2020","unstructured":"Roux A, Pallud J, Saffroy R,  High-grade gliomas in adolescents and young adults highlight histomolecular differences from their adult and pediatric counterparts. Neuro Oncol. 2020;22(8):1190\u20131202."},{"issue":"3","key":"b6","series-title":"Brain Tumor Pathol","first-page":"103","article-title":"Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution","volume":"34","author":"Yoshimoto K","year":"2017","unstructured":"Yoshimoto K, Hatae R, Sangatsuda Y,  Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution. Brain Tumor Pathol. 2017;34(3):103\u2013112."},{"issue":"5","key":"b7","series-title":"Acta Neuropathol","first-page":"669","article-title":"Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers","volume":"129","author":"Korshunov A","year":"2015","unstructured":"Korshunov A, Ryzhova M, Hovestadt V,  Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers. Acta Neuropathol. 2015;129(5):669\u2013678."},{"issue":"5","key":"b8","series-title":"Cancer Cell","first-page":"829","article-title":"Molecular, pathological, radiological, and immune profiling of non-brainstem pediatric high-grade glioma from the HERBY phase II randomized trial","volume":"33","author":"Mackay A","year":"2018","unstructured":"Mackay A, Burford A, Molinari V,  Molecular, pathological, radiological, and immune profiling of non-brainstem pediatric high-grade glioma from the HERBY phase II randomized trial. Cancer Cell. 2018;33(5):829\u2013842.e5."},{"issue":"1","key":"b9","series-title":"Acta Neuropathol","first-page":"137","article-title":"Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity","volume":"131","author":"Korshunov A","year":"2016","unstructured":"Korshunov A, Capper D, Reuss D,  Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity. Acta Neuropathol. 2016;131(1):137\u2013146."},{"issue":"10","key":"b10","series-title":"J Clin Oncol","first-page":"951","article-title":"Phase II, open-label, randomized, multicenter trial (HERBY) of bevacizumab in pediatric patients with newly diagnosed high-grade glioma","volume":"36","author":"Grill J","year":"2018","unstructured":"Grill J, Massimino M, Bouffet E,  Phase II, open-label, randomized, multicenter trial (HERBY) of bevacizumab in pediatric patients with newly diagnosed high-grade glioma. J Clin Oncol. 2018;36(10):951\u2013958."},{"issue":"2","key":"b11","series-title":"Am J Surg Pathol","first-page":"249","article-title":"Histone H3.3 G34-mutant diffuse gliomas in adults","volume":"46","author":"Wang L","year":"2022","unstructured":"Wang L, Shao L, Li H,  Histone H3.3 G34-mutant diffuse gliomas in adults. Am J Surg Pathol. 2022;46(2):249\u2013257."},{"issue":"1","key":"b12","series-title":"Neurooncol Adv","first-page":"a142","article-title":"Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults","volume":"2","author":"Schulte JD","year":"2020","unstructured":"Schulte JD, Buerki RA, Lapointe S,  Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults. Neurooncol Adv. 2020;2(1):a142."},{"issue":"1","key":"b13","series-title":"Sci Rep","first-page":"8368","article-title":"Histone H3K27M mutation overrides histological grading in pediatric gliomas","volume":"10","author":"Mosaab A","year":"2020","unstructured":"Mosaab A, El-Ayadi M, Khorshed EN,  Histone H3K27M mutation overrides histological grading in pediatric gliomas. Sci Rep. 2020;10(1):8368."},{"issue":"4","key":"b14","series-title":"Cancer Cell","first-page":"425","article-title":"Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma","volume":"22","author":"Sturm D","year":"2012","unstructured":"Sturm D, Witt H, Hovestadt V,  Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell. 2012;22(4):425\u2013437."},{"issue":"1","key":"b15","series-title":"Brain Tumor Pathol","first-page":"4","article-title":"H3 G34-mutant high-grade glioma","volume":"38","author":"Lim KY","year":"2021","unstructured":"Lim KY, Won JK, Park CK,  H3 G34-mutant high-grade glioma. Brain Tumor Pathol. 2021;38(1):4\u201313."},{"issue":"10","key":"b16","series-title":"Cancer","first-page":"1907","article-title":"The prognostic significance of further genotyping H3G34 diffuse hemispheric gliomas","volume":"128","author":"Vuong HG","year":"2022","unstructured":"Vuong HG, Le HT, Dunn IF. The prognostic significance of further genotyping H3G34 diffuse hemispheric gliomas. Cancer. 2022;128(10):1907\u20131912."},{"issue":"11","key":"b17","series-title":"Letter. Neuro Oncol","first-page":"1974","article-title":"Diffuse hemispheric glioma, H3 G34-mutant: genomic landscape of a new tumor entity and prospects for targeted therapy","volume":"23","author":"Lucas CG","year":"2021","unstructured":"Lucas CG, Mueller S, Reddy A,  Diffuse hemispheric glioma, H3 G34-mutant: genomic landscape of a new tumor entity and prospects for targeted therapy. Letter. Neuro Oncol. 2021;23(11):1974\u20131976."},{"issue":"6","key":"b18","series-title":"Cell","first-page":"1617","article-title":"Histone H3.3G34-mutant interneuron progenitors co-opt PDGFRA for gliomagenesis","volume":"183","author":"Chen CCL","year":"2020","unstructured":"Chen CCL, Deshmukh S, Jessa S,  Histone H3.3G34-mutant interneuron progenitors co-opt PDGFRA for gliomagenesis. Cell. 2020;183(6):1617\u20131633.e22."},{"issue":"5","key":"b19","series-title":"Cancer Discov","first-page":"512","article-title":"Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCN","volume":"3","author":"Bjerke L","year":"2013","unstructured":"Bjerke L, Mackay A, Nandhabalan M,  Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCN. Cancer Discov. 2013;3(5):512\u2013519."},{"issue":"615","key":"b20","series-title":"Sci Transl Med","first-page":"eabf7860","article-title":"Epigenetically defined therapeutic targeting in H3.3G34R\/V high-grade gliomas","volume":"13","author":"Sweha SR","year":"2021","unstructured":"Sweha SR, Chung C, Natarajan SK,  Epigenetically defined therapeutic targeting in H3.3G34R\/V high-grade gliomas. Sci Transl Med. 2021;13(615):eabf7860."},{"issue":"1","key":"b21","series-title":"Neurooncol Adv","first-page":"vdab061","article-title":"Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults","volume":"3","author":"Picart T","year":"2021","unstructured":"Picart T, Barritault M, Poncet D,  Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults. Neurooncol Adv. 2021;3(1):vdab061."},{"issue":"1","key":"b22","series-title":"J Neuroimaging","first-page":"17","article-title":"Neuroimaging features of diffuse hemispheric glioma, H3 G34-mutant: a case series and systematic review","volume":"32","author":"Kurokawa R","year":"2022","unstructured":"Kurokawa R, Baba A, Kurokawa M,  Neuroimaging features of diffuse hemispheric glioma, H3 G34-mutant: a case series and systematic review. J Neuroimaging. 2022;32(1):17\u201327."},{"issue":"1","key":"b23","series-title":"Commun Biol","first-page":"363","article-title":"Reciprocal H3.3 gene editing identifies K27M and G34R mechanisms in pediatric glioma including NOTCH signaling","volume":"3","author":"Chen KY","year":"2020","unstructured":"Chen KY, Bush K, Klein RH,  Reciprocal H3.3 gene editing identifies K27M and G34R mechanisms in pediatric glioma including NOTCH signaling. Commun Biol. 2020;3(1):363."},{"issue":"10","key":"b24","series-title":"J Neuropathol Exp Neurol","first-page":"1038","article-title":"Low-grade gemistocytic morphology in H3 G34R-mutant gliomas and concurrent K27M mutation: clinicopathologic findings","volume":"79","author":"Morris M","year":"2020","unstructured":"Morris M, Driscoll M, Henson JW,  Low-grade gemistocytic morphology in H3 G34R-mutant gliomas and concurrent K27M mutation: clinicopathologic findings. J Neuropathol Exp Neurol. 2020;79(10):1038\u20131043."},{"issue":"12","key":"b25","series-title":"Clin Nucl Med","first-page":"895","article-title":"Characterization of diffuse gliomas with histone H3-G34 mutation by MRI and dynamic 18F-FET PET","volume":"43","author":"Vettermann FJ","year":"2018","unstructured":"Vettermann FJ, Felsberg J, Reifenberger G,  Characterization of diffuse gliomas with histone H3-G34 mutation by MRI and dynamic 18F-FET PET. Clin Nucl Med. 2018;43(12):895\u2013898."},{"issue":"2","key":"b26","series-title":"Radiology","first-page":"560","article-title":"MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set","volume":"267","author":"Gutman DA","year":"2013","unstructured":"Gutman DA, Cooper LA, Hwang SN,  MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. Radiology. 2013;267(2):560\u2013569."},{"issue":"4","key":"b27","series-title":"Eur J Cancer","first-page":"441","article-title":"Radiomics: extracting more information from medical images using advanced feature analysis","volume":"48","author":"Lambin P","year":"2012","unstructured":"Lambin P, Rios-Velazquez E, Leijenaar R,  Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48(4):441\u2013446."},{"issue":"4","key":"b28","series-title":"J Nucl Med","first-page":"488","article-title":"Introduction to radiomics","volume":"61","author":"Mayerhoefer ME","year":"2020","unstructured":"Mayerhoefer ME, Materka A, Langs G,  Introduction to radiomics. J Nucl Med. 2020;61(4):488\u2013495."},{"issue":"1","key":"b29","series-title":"Radiology","first-page":"168","article-title":"Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features","volume":"273","author":"Gevaert O","year":"2014","unstructured":"Gevaert O, Mitchell LA, Achrol AS,  Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features. Radiology. 2014;273(1):168\u2013174."},{"issue":"3","key":"b30","series-title":"Brain","first-page":"1151","article-title":"An MRI radiomics approach to predict survival and tumour-infiltrating macrophages in gliomas","volume":"145","author":"Li G","year":"2022","unstructured":"Li G, Li L, Li Y,  An MRI radiomics approach to predict survival and tumour-infiltrating macrophages in gliomas. Brain. 2022;145(3):1151\u20131161."},{"issue":"3","key":"b31","series-title":"Eur Radiol","first-page":"1813","article-title":"MRI-based radiomics signature and clinical factor for predicting H3K27M mutation in pediatric high-grade gliomas located in the midline of the brain","volume":"32","author":"Wu C","year":"2022","unstructured":"Wu C, Zheng H, Li J,  MRI-based radiomics signature and clinical factor for predicting H3K27M mutation in pediatric high-grade gliomas located in the midline of the brain. Eur Radiol. 2022;32(3):1813\u20131822."},{"issue":"2","key":"b32","series-title":"Neuroimage","first-page":"782","article-title":"FSL","volume":"62","author":"Jenkinson M","year":"2012","unstructured":"Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM. FSL. Neuroimage. 2012;62(2):782\u2013790."},{"issue":"8","key":"b33","series-title":"PLoS One","first-page":"e0237587","article-title":"FeAture Explorer (FAE): a tool for developing and comparing radiomics models","volume":"15","author":"Song Y","year":"2020","unstructured":"Song Y, Zhang J, Zhang YD,  FeAture Explorer (FAE): a tool for developing and comparing radiomics models. PLoS One. 2020;15(8):e0237587."},{"issue":"1","key":"b34","series-title":"Sci Rep","first-page":"24039","article-title":"Research on expansion and classification of imbalanced data based on SMOTE algorithm","volume":"11","author":"Wang S","year":"2021","unstructured":"Wang S, Dai Y, Shen J, Xuan J. Research on expansion and classification of imbalanced data based on SMOTE algorithm. Sci Rep. 2021;11(1):24039."},{"issue":"2","key":"b35","series-title":"Top Magn Reson Imaging","first-page":"83","article-title":"Updates in pediatric malignant gliomas","volume":"29","author":"Gon\u00e7alves FG","year":"2020","unstructured":"Gon\u00e7alves FG, Alves CAPF, Vossough A. Updates in pediatric malignant gliomas. Top Magn Reson Imaging. 2020;29(2):83\u201394."},{"issue":"12","key":"b36","series-title":"Zhonghua Bing Li Xue Za Zhi","first-page":"1267","article-title":"High-grade gliomas with H3 G34R mutation: a clinicopathological study. Article in Chinese","volume":"49","author":"Wang W","year":"2020","unstructured":"Wang W, Wang LM, Lu DH,  High-grade gliomas with H3 G34R mutation: a clinicopathological study. Article in Chinese. Zhonghua Bing Li Xue Za Zhi. 2020;49(12):1267\u20131271."},{"issue":"4","key":"b37","series-title":"Neurosurgery","first-page":"339","article-title":"Use of high-field intraoperative magnetic resonance imaging to enhance the extent of resection of enhancing and nonenhancing gliomas","volume":"74","author":"Mohammadi AM","year":"2014","unstructured":"Mohammadi AM, Sullivan TB, Barnett GH,  Use of high-field intraoperative magnetic resonance imaging to enhance the extent of resection of enhancing and nonenhancing gliomas. Neurosurgery. 2014;74(4):339-349."},{"issue":"2","key":"b38","series-title":"Radiology","first-page":"484","article-title":"Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor","volume":"272","author":"Jain R","year":"2014","unstructured":"Jain R, Poisson LM, Gutman D,  Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor. Radiology. 2014;272(2):484\u2013493."},{"key":"b39","series-title":"Neuroimage Clin","first-page":"306","article-title":"MRI features predict p53 status in lower-grade gliomas via a machine-learning approach","volume":"17","author":"Li Y","year":"2017","unstructured":"Li Y, Qian Z, Xu K,  MRI features predict p53 status in lower-grade gliomas via a machine-learning approach. Neuroimage Clin. 2017;17:306\u2013311."},{"key":"b40","series-title":"Clin Neurol Neurosurg","first-page":"114","article-title":"Quantitative texture analysis in the prediction of IDH status in low-grade gliomas","volume":"164","author":"Jakola AS","year":"2018","unstructured":"Jakola AS, Zhang YH, Skjulsvik AJ,  Quantitative texture analysis in the prediction of IDH status in low-grade gliomas. Clin Neurol Neurosurg. 2018;164:114\u2013120."},{"issue":"4","key":"b41","series-title":"J Biophotonics","first-page":"e201700072","article-title":"Pixel classification method in optical coherence tomography for tumor segmentation and its complementary usage with OCT microangiography","volume":"11","author":"Moiseev A","year":"2018","unstructured":"Moiseev A, Snopova L, Kuznetsov S,  Pixel classification method in optical coherence tomography for tumor segmentation and its complementary usage with OCT microangiography. J Biophotonics. 2018;11(4):e201700072."},{"issue":"1","key":"b42","series-title":"Neuro Oncol","first-page":"109","article-title":"Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas","volume":"19","author":"Zhang B","year":"2017","unstructured":"Zhang B, Chang K, Ramkissoon S,  Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas. Neuro Oncol. 2017;19(1):109\u2013117."}],"container-title":["Journal of Neurosurgery: Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/33\/3\/article-p236.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/33\/3\/article-p236.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/33\/3\/article-p236.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T13:05:03Z","timestamp":1733490303000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/33\/3\/article-p236.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":42,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3171\/2023.10.peds23235","relation":{},"ISSN":["1933-0707","1933-0715"],"issn-type":[{"value":"1933-0707","type":"print"},{"value":"1933-0715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]}}}